Search

everythinglearnresearchcommunity

for

Search:↓

Timely treatment of eosinophilic asthma in rheumatic disease patients can prevent organ damage.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Shorter CAG repeats may cause hair and skin issues, while longer ones may link to acne.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments for male hypogonadism are effective and should be personalized.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Shampoos are designed to clean and improve hair and scalp health, with specific ingredients for different hair types and conditions.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Pregnancy often causes skin changes like darkening, stretch marks, and hair growth, which may improve after childbirth.

Some birth control pills have a higher risk of blood clots than others.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Spironolactone can reduce hair growth in women with hirsutism.